Affordable Access

Effectiveness of tamsulosin in treatment of lower urinary tract symptoms in women

Authors
Publisher
Chulalongkorn University
Publication Date
Keywords
  • Tamsulosin
  • Urinary Tract Infections
  • Urinary Organs--Diseases
  • Urination Disorders
Disciplines
  • Medicine

Abstract

Objective: To compare the effectiveness of Tamsulosin in treatment of lower urinary tract symptoms (LUTS) in women. Design: Randomized double-blind placebo controlled trial Setting: Ramathibodi Hospital. Method: One hundred and fifty patients who were in eligible criteria at urological outpatient department were randomly allocated into 2 groups by block randomization. Group 1 received 0.2 mg of Tamsulosin and group 2 received placebo orally for 1 month in a double-blind fashion. Outcome variables included mean change of International prostate symptom score (IPSS), mean change of urinary flow rate and any adverse effect. Results: Mean change of IPSS (SD) were -5.2 (6.1) in Tamsulosin group and -2.8 (6.0) in placebo group. There was considered statistically significant. (exact p-value = 0.042) by Mann-Whitney U test. Mean change of urinary flow rate (SD) were 0.6 (2.6) ml/s in Tamsulosin group and -0.6 (2.5) ml/s in placebo group. There was considered statistically significant (exact p-value = 0.008). There were two patients in Tamsulosin group who had dizziness and asthenia. No any other adverse effect was detected. Conclusion: Tamsulosin was more efficacious than placebo in treatment of LUTS in women and should be used in selected female patients with LUTS.

There are no comments yet on this publication. Be the first to share your thoughts.